Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of its increased transmissibility and its numerous spike mutations, which have the potential to evade neutralizing antibodies elicited by COVID-19 vaccines. Here we evaluated the effects of a heterologous BNT162b2 mRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Then, Eddy, Lucas, Carolina, Monteiro, Valter Silva, Miric, Marija, Brache, Vivian, Cochon, Leila, Vogels, Chantal B. F., Malik, Amyn A., De la Cruz, Elena, Jorge, Aidelis, De los Santos, Margarita, Leon, Patricia, Breban, Mallery I., Billig, Kendall, Yildirim, Inci, Pearson, Claire, Downing, Randy, Gagnon, Emily, Muyombwe, Anthony, Razeq, Jafar, Campbell, Melissa, Ko, Albert I., Omer, Saad B., Grubaugh, Nathan D., Vermund, Sten H., Iwasaki, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938264/
https://www.ncbi.nlm.nih.gov/pubmed/35051990
http://dx.doi.org/10.1038/s41591-022-01705-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938264/
https://www.ncbi.nlm.nih.gov/pubmed/35051990
http://dx.doi.org/10.1038/s41591-022-01705-6

Ejemplares similares